Xueba’s medical black technology system

Chapter 171 Asking for help from major research institutions

After Lu Liang’s research appeared in Science.

All over the world, scientific researchers or related research institutions engaged in tumor research are excited at this moment.

The moment they read Lu Liang's article, they almost made the same decision unanimously.

Reproduce the test immediately!

If the test is repeated successfully and proves that there is no problem with the drug, then they can conduct further research based on Lu Liangyuan's work and unearth more results.

They can even apply Lu Liang's ideas to other cancer treatments.

Of course, all this is predicated on the successful reproduction of the test.

This is why they are eager to replicate the experiment.

However, these researchers and research institutions soon discovered the same problem.

That is, Lu Liang did not include the method of cultivating monoclonal antibody drugs in the article.

This has resulted in them currently missing one of the most critical things before reproducing the test.

They don't have drug samples!

At this moment, these professors and experts were dumbfounded.

"Jingle Bell"

The harsh ringing of the phone woke Lu Liang from his sleep. Lu Liang rubbed his eyes and got up from the bed with a sigh.

Then he opened the pillow and picked up the mobile phone he had stuffed under the pillow before going to bed at night.

Then, Lu Liang glanced at the screen of his mobile phone, looking a little surprised.

It was Ji Hong's call.

Ji Hong rarely called him, and usually sent him direct messages, waiting for Lu Liang to go and see it himself.

Unless it's something important.

Lu Liang answered Ji Hong's call, and Ji Hong's laughter came from the other end of the phone: "Xiao Lu, you should not be awake yet."

It's only around six o'clock now, so of course I haven't woken up yet.

Lu Liangliang complained silently.

However, Lu Liang still asked: "Teacher, is there something wrong?"

Ji Hong said, "It's nothing important. I just want to tell you that when you wake up later, remember to check your mailbox. Don't forget it."

As if he was afraid that Lu Liang would forget, Ji Hong repeatedly warned him.

Check your email?
Lu Liang was a little confused. He didn't know for a while whether this matter was important or not.

He said it was not important, but Ji Hong called so early and warned him repeatedly.

When it came to important things, Ji Hong was not in a hurry and asked him to read it after he woke up.

After hanging up the phone, Lu Liang curiously opened the email on his phone. He wanted to see what was going on.

I don't know if it was because the phone had been used for too long and the memory was not cleared. When he opened the mailbox, Lu Liang saw that the mailbox interface was visibly stuck.

Immediately after
"Ding dong! Ding dong! Ding dong! Ding dong!."

The message notification sound on the phone sounded like crazy, and countless emails were pouring out of the phone like an avalanche, drowning Lu Liang.

In just a moment, Lu Liang saw that the number of unread emails in his mailbox reached 99+.

Lu Liang was stunned when he saw this scene. He had no idea what was happening.

The last email was sent just 2 minutes ago. "Ding dong!"

Just when Lu Liang was stunned, another email was sent.

This made Lu Liang dumbfounded. Why did so many people suddenly send him emails?
After coming back to his senses, Lu Liang quickly opened the email just sent to see what was going on.

"Dear Dr. Lu, I am Siko Joseph, a professor at New York University."

"Yesterday, our team members read your latest paper in the Science journal. After reading your research, we were very excited. We were deeply inspired by your research."

"We want to try to reproduce the experiment in your article, but due to technical reasons, we do not know the method of cultivating the special monoclonal antibody in your article, so we would like to ask you about the cultivation of this special monoclonal antibody. method."

"If you are willing to provide the cultivation method of this monoclonal antibody, or provide us with a small sample of the drug, we will be grateful. Thank you."

When he saw the content of the email, Lu Liang was stunned for a moment.

Later, Lu Liang casually opened another email. This email came from a staff member of a scientific research institution in England. The content of the email was exactly the same, requesting some technical support.

Lu Liang opened several more emails one after another.

These emails include emails from professors at Stanford Medicine and emails from Cleveland Medical Center. The content of the emails is basically the same.

In addition to this, there were also invitations from several academic journals in the first region, asking Lu Liang if he would be willing to publish the method of cultivating that special monoclonal antibody in their journals.

Lu Liang couldn't help scratching his head when he saw these emails.

Although Ji Hong once told him that this article would have a great influence, Lu Liang never expected that the influence would be so great.

Moreover, this is not the first time he has published an article in CNS. He has also published a paper in the main issue of Nature before, which was about hemophilia research.

Why didn't that paper cause such a big stir?
But Lu Liang soon figured out something. For the paper on hemophilia, the system gave 1 source point, while for the paper on lung cancer, the system gave 1.5 source points.

Can the difference be the same?

After understanding the difference, Lu Liang focused his attention on the email again.

In fact, experimental replication is an extremely common thing in academia.

But for both the publisher of the paper and other researchers, experimental replication is a good thing.

For the publisher of a paper, the more people reproduce the experiment, the more it can reflect the influence of the article and its own strength.

At the same time, other researchers will also publish the results of the replication experiments, which is tantamount to proving that the publisher's research is genuine.

But there is a situation where the publisher of the paper does not want others to replicate his experiment.

That is fraud.

Because from the beginning, the experiment was irreproducible.

For those researchers who conduct replication experiments, the benefit they can gain is that they can obtain some results more easily.

It feels like the biggest apple has been picked by the giant, but there are still some small apples left, which the giant has no interest in picking.

And they can stand on the shoulders of giants and pick these little apples.

Although the apple is a bit smaller, it is still a success.

Therefore, Lu Liang did not mind providing these researchers with a little help with drug samples.

But the problem is, these people are from all over the world, how can they provide drug samples?

Lu Liang had never encountered this kind of problem before and had no experience in dealing with it.

In desperation, Lu Liang could only call Ji Hong again.

(End of this chapter)